Trevi Therapeutics (TRVI) Return on Capital Employed Growth (3y) (2022 - 2026)
Trevi Therapeutics (TRVI) Return on Capital Employed Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Trevi Therapeutics |
2.08 Bn |
1.91 Bn |
- |
15.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
15.00 |
| Dec 31, 2025 |
81.00 |
| Sep 30, 2025 |
914.00 |
| Jun 30, 2025 |
4,034.00 |
| Mar 31, 2025 |
9,672.00 |
| Dec 31, 2024 |
8,066.00 |
| Sep 30, 2024 |
5,370.00 |
| Jun 30, 2024 |
4,446.00 |
| Mar 31, 2024 |
3,191.00 |
| Dec 31, 2023 |
3,163.00 |
| Sep 30, 2023 |
3,237.00 |
| Jun 30, 2023 |
3,963.00 |
| Mar 31, 2023 |
3,244.00 |
| Dec 31, 2022 |
1,945.00 |
| Sep 30, 2022 |
445.00 |
| Jun 30, 2022 |
-1,509.00 |
| Mar 31, 2022 |
5,135.00 |
